Krystal Biotech, Inc. (KRYS)

Krystal Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 7, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	7,144	4,506	3,499	2,040	1,742	1,182
Market Cap Growth	58.58%	28.76%	71.56%	17.08%	47.34%	23.36%
Enterprise Value	6,289	3,819	2,909	1,642	1,388	899
Last Close Price	246.37	156.66	124.06	79.22	69.95	60.00
PE Ratio	36.98	50.54	320.10	-	-	-
Forward PE	34.87	33.31	-	-	-	-
PS Ratio	19.05	15.51	69.02	-	-	-
PB Ratio	6.28	4.76	4.49	3.91	2.94	4.05
P/TBV Ratio	6.28	4.76	4.49	3.91	2.94	4.05
P/FCF Ratio	43.14	37.81	-	-	-	-
P/OCF Ratio	40.55	36.51	-	-	-	-
EV/Sales Ratio	16.85	13.15	57.38	-	-	-
EV/EBITDA Ratio	39.39	36.14	-	-	-	-
EV/EBIT Ratio	39.72	37.01	-	-	-	-
EV/FCF Ratio	37.98	32.04	-	-	-	-
Debt / Equity Ratio	0.01	0.01	0.01	0.02	0.01	0.01
Debt / EBITDA Ratio	0.06	0.07	-	-	-	-
Debt / FCF Ratio	0.06	0.06	-	-	-	-
Asset Turnover	0.34	0.31	0.07	-	-	-
Inventory Turnover	0.76	1.20	-	-	-	-
Quick Ratio	9.43	6.89	17.35	13.14	17.02	17.56
Current Ratio	10.14	7.28	17.77	13.30	17.18	17.80
Return on Equity (ROE)	19.66%	10.34%	1.68%	-25.09%	-15.71%	-13.00%
Return on Assets (ROA)	8.91%	6.88%	-8.83%	-12.80%	-9.32%	-7.93%
Return on Capital (ROIC)	9.70%	7.41%	-9.22%	-13.38%	-9.73%	-8.21%
Return on Capital Employed (ROCE)	13.80%	10.80%	-12.40%	-22.90%	-11.60%	-11.20%
Earnings Yield	2.78%	1.98%	0.31%	-6.86%	-3.99%	-2.72%
FCF Yield	2.32%	2.65%	-2.88%	-7.53%	-6.67%	-3.46%
Buyback Yield / Dilution	-1.34%	-7.16%	-8.87%	-14.85%	-18.15%	-18.15%

Updated Nov 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q